Skip to main content

MoneyWorks4Me

Jubilant Life Sciences informs about quarterly statement on investor complaints

11 Apr 2016 Evaluate

Jubilant Life Sciences has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1763.65
Dr. Reddys Labs. 1344.00
Cipla 1370.30
Lupin 1983.80
Zydus Lifesciences 1183.75
View more..